lasofoxifene,fulvestrant,alpelisib,abemaciclib
sermonix,ligand,eli lilly,pfizer,novartis
['alpelisib', 'fulv', 'lasofoxifene', 'elaine 2', 'breast', 'abemaciclib']
elaine 2 presented #asco22 in the big room: lasofoxifene plus abemaciclib in patients with advanced er+ breast cancer with esr1 mutations, heavily pre-treated: prior cdki, 80% prior fulv, 50% had chemo: pfs 56wk, orr 50%, cbr 70%. responses even after previous abema and alpelisib 
CEO, Chief Medical Officer, Sermonix: clinical & research interest in breast cancer, menopause, osteoporosis, and sexual health